Literature DB >> 27233964

A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.

Li-Guo Jia1, Giorgos Bamias2, Kristen O Arseneau1, Linda C Burkly3, Eddy C Y Wang4, Dennis Gruszka1, Theresa T Pizarro5, Fabio Cominelli6.   

Abstract

TNF-like cytokine 1A (TL1A) is expressed on APCs and provides costimulatory signals to activated lymphocytes that bear its functional receptor, death receptor 3 (DR3). TL1A/DR3 signaling is involved in the pathogenesis of human and experimental inflammatory bowel disease. In the current study, we investigated the role of this cytokine/receptor pair in acute intestinal injury/repair pathways. We demonstrate that intact DR3 signaling protected mice from acute dextran sodium sulfate colitis because DR3(-/-) mice showed more severe mucosal inflammation and increased mortality. DR3(-/-) mice were compromised in their ability to maintain adequate numbers of CD4(+)CD25(+)Foxp3(+) regulatory T cells in response to acute mucosal damage. This defect in immune regulation led to a nonspecific upregulation of effector proinflammatory pathways, which was most prominent for the Th17 immunophenotype. TL1A(-/-) mice were similarly more susceptible to dextran sodium sulfate colitis, although without mortality and with delayed kinetics compared with DR3(-/-) mice, and also displayed significantly reduced numbers of regulatory T cells. Infection of DR3(-/-) mice with Salmonella typhimurium was associated with defective microbial clearance and elevated bacterial load. Taken together, our findings indicate a novel protective role for the TL1A/DR3 axis in the regulation of mucosal homeostasis during acute intestinal injury/repair, which contrasts with its known pathogenic function during chronic intestinal inflammation.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27233964      PMCID: PMC5016081          DOI: 10.4049/jimmunol.1502466

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Insights into TL1A and IBD pathogenesis.

Authors:  David Q Shih; Kathrin S Michelsen; Robert J Barrett; Eva Biener-Ramanujan; Rivkah Gonsky; Xiaolan Zhang; Stephan R Targan
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 2.  Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

Authors:  Casey T Weaver; Robin D Hatton
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

3.  TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

Authors:  Thi Sau Migone; Jun Zhang; Xia Luo; Li Zhuang; Cecil Chen; Bugen Hu; June S Hong; James W Perry; Su Fang Chen; Joe X H Zhou; Yun Hee Cho; Stephen Ullrich; Palanisamy Kanakaraj; Jeffrey Carrell; Ernest Boyd; Henrik S Olsen; Gang Hu; Laurie Pukac; Ding Liu; Jian Ni; Sunghee Kim; Reiner Gentz; Ping Feng; Paul A Moore; Steve M Ruben; Ping Wei
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

4.  Abatacept for Crohn's disease and ulcerative colitis.

Authors:  William J Sandborn; Jean-Frederic Colombel; Bruce E Sands; Paul Rutgeerts; Stephan R Targan; Remo Panaccione; Brian Bressler; Karl Geboes; Stefan Schreiber; Richard Aranda; Sheila Gujrathi; Allison Luo; Yun Peng; Luisa Salter-Cid; Stephen B Hanauer
Journal:  Gastroenterology       Date:  2012-04-12       Impact factor: 22.682

5.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.

Authors:  Giorgos Bamias; Charles Martin; Marco Marini; Sharon Hoang; Margarita Mishina; William G Ross; Muhammadreza A Sachedina; Charles M Friel; James Mize; Stephen J Bickston; Theresa T Pizarro; Ping Wei; Fabio Cominelli
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

Review 7.  The role of TNF superfamily members in T-cell function and diseases.

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

8.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

9.  TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality.

Authors:  Emiko Mizoguchi; Yuriko Hachiya; Mayumi Kawada; Katsuya Nagatani; Atsuhiro Ogawa; Ken Sugimoto; Atsushi Mizoguchi; Daniel K Podolsky
Journal:  Gastroenterology       Date:  2007-12-04       Impact factor: 22.682

10.  The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.

Authors:  F Meylan; Y-J Song; I Fuss; S Villarreal; E Kahle; I-J Malm; K Acharya; H L Ramos; L Lo; M M Mentink-Kane; T A Wynn; T-S Migone; W Strober; R M Siegel
Journal:  Mucosal Immunol       Date:  2010-10-27       Impact factor: 7.313

View more
  14 in total

1.  Protective Role for TWEAK/Fn14 in Regulating Acute Intestinal Inflammation and Colitis-Associated Tumorigenesis.

Authors:  Luca Di Martino; Maneesh Dave; Paola Menghini; Wei Xin; Kristen O Arseneau; Theresa T Pizarro; Fabio Cominelli
Journal:  Cancer Res       Date:  2016-09-09       Impact factor: 12.701

2.  Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.

Authors:  Jim G Castellanos; Viola Woo; Monica Viladomiu; Gregory Putzel; Svetlana Lima; Gretchen E Diehl; Andrew R Marderstein; Jorge Gandara; Alexendar R Perez; David R Withers; Stephan R Targan; David Q Shih; Ellen J Scherl; Randy S Longman
Journal:  Immunity       Date:  2018-12-11       Impact factor: 31.745

3.  T cell expression of IL-18R and DR3 is essential for non-cognate stimulation of Th1 cells and optimal clearance of intracellular bacteria.

Authors:  Oanh H Pham; Hope O'Donnell; Aymen Al-Shamkhani; Tobias Kerrinnes; Renée M Tsolis; Stephen J McSorley
Journal:  PLoS Pathog       Date:  2017-08-17       Impact factor: 6.823

4.  A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis.

Authors:  Paola Menghini; Luca Di Martino; Loris R Lopetuso; Daniele Corridoni; Joshua C Webster; Wei Xin; Kristen O Arseneau; Minh Lam; Theresa T Pizarro; Fabio Cominelli
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

5.  Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease.

Authors:  Arianne C Richard; James E Peters; Natalia Savinykh; James C Lee; Eric T Hawley; Françoise Meylan; Richard M Siegel; Paul A Lyons; Kenneth G C Smith
Journal:  PLoS Genet       Date:  2018-09-10       Impact factor: 5.917

Review 6.  TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.

Authors:  Vassilis Valatas; George Kolios; Giorgos Bamias
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561

7.  Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation.

Authors:  Jingyu Li; Wenli Shi; Hanxiao Sun; Yan Ji; Yuqin Chen; Xiaohuan Guo; Huiming Sheng; Jie Shu; Liang Zhou; Ting Cai; Ju Qiu
Journal:  Nat Commun       Date:  2019-07-29       Impact factor: 14.919

8.  Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.

Authors:  Ludovica F Buttó; Li-Guo Jia; Kristen O Arseneau; Hiroshi Tamagawa; Alex Rodriguez-Palacios; Zhaodong Li; Carlo De Salvo; Theresa T Pizarro; Giorgos Bamias; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

9.  Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.

Authors:  Zhaodong Li; Ludovica F Buttó; Kristine-Anne Buela; Li-Guo Jia; Minh Lam; John D Ward; Theresa T Pizarro; Fabio Cominelli
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

10.  TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.

Authors:  Bruna Oriol-Tordera; Alex Olvera; Clara Duran-Castells; Anuska Llano; Beatriz Mothe; Marta Massanella; Judith Dalmau; Carmela Ganoza; Jorge Sanchez; Maria Luz Calle; Bonaventura Clotet; Javier Martinez-Picado; Eugènia Negredo; Julià Blanco; Dennis Hartigan-O'Connor; Christian Brander; Marta Ruiz-Riol
Journal:  J Immunol       Date:  2020-11-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.